Displaying publications 1 - 20 of 419 in total

Abstract:
Sort:
  1. Sadana R, Khosla R, Gisselquist R, Sen K
    Bull World Health Organ, 2024 May 01;102(5):299-299A.
    PMID: 38693944 DOI: 10.2471/BLT.24.291722
    Matched MeSH terms: Global Health*
  2. Van Coillie S, Prévot J, Sánchez-Ramón S, Lowe DM, Borg M, Autran B, et al.
    Front Immunol, 2024;15:1430678.
    PMID: 39055704 DOI: 10.3389/fimmu.2024.1430678
    The International Patient Organisation for Primary Immunodeficiencies (IPOPI) held its second Global Multi-Stakeholders' Summit, an annual stimulating and forward-thinking meeting uniting experts to anticipate pivotal upcoming challenges and opportunities in the field of primary immunodeficiency (PID). The 2023 summit focused on three key identified discussion points: (i) How can immunoglobulin (Ig) therapy meet future personalized patient needs? (ii) Pandemic preparedness: what's next for public health and potential challenges for the PID community? (iii) Diagnosing PIDs in 2030: what needs to happen to diagnose better and to diagnose more? Clinician-Scientists, patient representatives and other stakeholders explored avenues to improve Ig therapy through mechanistic insights and tailored Ig preparations/products according to patient-specific needs and local exposure to infectious agents, amongst others. Urgency for pandemic preparedness was discussed, as was the threat of shortage of antibiotics and increasing antimicrobial resistance, emphasizing the need for representation of PID patients and other vulnerable populations throughout crisis and care management. Discussion also covered the complexities of PID diagnosis, addressing issues such as global diagnostic disparities, the integration of patient-reported outcome measures, and the potential of artificial intelligence to increase PID diagnosis rates and to enhance diagnostic precision. These proceedings outline the outcomes and recommendations arising from the 2023 IPOPI Global Multi-Stakeholders' Summit, offering valuable insights to inform future strategies in PID management and care. Integral to this initiative is its role in fostering collaborative efforts among stakeholders to prepare for the multiple challenges facing the global PID community.
    Matched MeSH terms: Global Health*
  3. Patwardhan B, Wieland LS, Aginam O, Chuthaputti A, Ghelman R, Ghods R, et al.
    J Integr Complement Med, 2023 Sep;29(9):527-530.
    PMID: 37713586 DOI: 10.1089/jicm.2023.29121.editorial
    Matched MeSH terms: Global Health*
  4. McCoy D, Khosla R
    Nat Med, 2023 Sep;29(9):2158-2159.
    PMID: 37420099 DOI: 10.1038/s41591-023-02446-w
    Matched MeSH terms: Global Health*
  5. Vora NM, Narayan S, Aluso A, Donatti CI, El Omrani O, Hannah L, et al.
    Lancet, 2024 Sep 07;404(10456):913-915.
    PMID: 39146950 DOI: 10.1016/S0140-6736(24)01599-X
    Matched MeSH terms: Global Health*
  6. Leung AKC, Lam JM, Leong KF
    Curr Pediatr Rev, 2020;16(1):33-42.
    PMID: 31544694 DOI: 10.2174/1573396315666190717114131
    BACKGROUND: Scabies is a skin disease caused by an obligate human parasite mite Sarcoptes scabiei var. hominis. Children under the age of two and elderly individuals are at the greatest risk. Knowledge of this condition is important for an early diagnosis to be made and treatment to be initiated.

    OBJECTIVE: The review aimed to familiarize physicians with the clinical manifestations, diagnosis, evaluation, and management of scabies.

    METHODS: A search was conducted using Pubmed with the built-in "Clinical Queries" tool. The search term "Scabies" was used. The categories of "epidemiology", "diagnosis", "therapy", "prevention" and "prognosis" had a limited scope for primary clinical studies. Meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews were included. Only papers published in the English language were included. A descriptive, narrative synthesis was provided of the retrieved articles.

    RESULTS: Worldwide, scabies affects 200 to 300 million individuals annually. The average prevalence is estimated to be 5 to 10% in children of developing countries. Transmission usually occurs after close prolonged skin-to-skin contact. Classic scabies is characterized by an erythematous papular eruption, serpiginous burrows, and intense pruritus. Sites of predilection include the webs of the fingers, volar wrists, lateral aspects of fingers, extensor surfaces of elbows and knees, waist, navel, abdomen, buttocks, groins, and, genitals. A clinical diagnosis of classic scabies can be made on the basis of the history and clinical findings. Other clinical variants include crusted scabies, nodular scabies, and bullous scabies. Finding the mite, ova, or fecal pellets on microscopic examination of scrapings taken from skin lesions confirms the diagnosis of scabies infestation. For eradication of scabies mites, the drugs of choice are topical permethrin and oral ivermectin.

    CONCLUSION: Scabies is a highly contagious parasitic cutaneous disease that is stigmatising and debilitating. Increased awareness, accurate diagnosis, and prompt treatment are essential for the effective control of scabies and for the prevention of the spread of the disease.

    Matched MeSH terms: Global Health
  7. Whitmee S, Haines A, Beyrer C, Boltz F, Capon AG, de Souza Dias BF, et al.
    Lancet, 2015 Nov 14;386(10007):1973-2028.
    PMID: 26188744 DOI: 10.1016/S0140-6736(15)60901-1
    Matched MeSH terms: Global Health*
  8. Hawkes S, Allotey P, Elhadj AS, Clark J, Horton R
    Lancet, 2020 08 22;396(10250):521-522.
    PMID: 32763153 DOI: 10.1016/S0140-6736(20)31547-6
    Matched MeSH terms: Global Health*
  9. Khosla R, Allotey P, Gruskin S
    BMJ Glob Health, 2020 08;5(8).
    PMID: 32819918 DOI: 10.1136/bmjgh-2020-003548
    Matched MeSH terms: Global Health*
  10. Saleem Z, Hassali MA, Hashmi FK
    Lancet Infect Dis, 2018 10;18(10):1066-1067.
    PMID: 30303099 DOI: 10.1016/S1473-3099(18)30516-4
    Matched MeSH terms: Global Health*
  11. Hashim JH, Hashim Z, Hod R, Jalaludin J, Mohamed N, Karuppannan S, et al.
    Rev Environ Health, 2023 Jun 27;38(2):349-359.
    PMID: 35468665 DOI: 10.1515/reveh-2022-0030
    OBJECTIVES: Environmental risk factors contribute to 24% of the global burden of disease from all causes in disability-adjusted life years (DALYs), and to 23% of all global deaths. Malaysia being an advanced developing country, there is a need to prioritise environmental health issues to enable environmental health practitioners to focus on the most significant and urgent environmental health concerns.

    CONTENT: This project was undertaken by a Thematic Working Group on Environmental Health Experts (TWG 10) under the Malaysian National Environmental Health Action Plan. Sixteen pre-selected environmental health issues were presented to a two focus group discussions among 20 environmental health and related professionals who then scored each issue on its magnitude and severity scale.

    SUMMARY: The total of these scores generated a list of priority environmental health issues for Malaysia. Children environmental health came out as the environmental health issue of the highest priority.

    OUTLOOK: We hope that this list of priority environmental health issues will be used for prioritising academic and professional manpower training, research funding allocation and planning for intervention programmes by various stakeholders.

    Matched MeSH terms: Global Health*
  12. McCoy D, Kapilashrami A, Kumar R, Rhule E, Khosla R
    Bull World Health Organ, 2024 Feb 01;102(2):130-136.
    PMID: 38313156 DOI: 10.2471/BLT.23.289949
    Colonialism, which involves the systemic domination of lands, markets, peoples, assets, cultures or political institutions to exploit, misappropriate and extract wealth and resources, affects health in many ways. In recent years, interest has grown in the decolonization of global health with a focus on correcting power imbalances between high-income and low-income countries and on challenging ideas and values of some wealthy countries that shape the practice of global health. We argue that decolonization of global health must also address the relationship between global health actors and contemporary forms of colonialism, in particular the current forms of corporate and financialized colonialism that operate through globalized systems of wealth extraction and profiteering. We present a three-part agenda for action that can be taken to decolonize global health. The first part relates to the power asymmetries that exist between global health actors from high-income and historically privileged countries and their counterparts in low-income and marginalized settings. The second part concerns the colonization of the structures and systems of global health governance itself. The third part addresses how colonialism occurs through the global health system. Addressing all forms of colonialism calls for a political and economic anticolonialism as well as social decolonization aimed at ensuring greater national, racial, cultural and knowledge diversity within the structures of global health.
    Matched MeSH terms: Global Health*
  13. Ahamad F, Mahmood J, Lacey-Hall O, Ganeson M, Ariff HZ, Lim TJ
    Lancet Planet Health, 2024 Jul;8(7):e426-e427.
    PMID: 38969468 DOI: 10.1016/S2542-5196(24)00110-4
    Matched MeSH terms: Global Health*
  14. Nassiri-Ansari T, Rhule ELM
    BMJ Glob Health, 2024 Apr 11;9(4).
    PMID: 38604753 DOI: 10.1136/bmjgh-2023-014235
    INTRODUCTION: Race and gender were intimately intertwined aspects of the colonial project, used as key categories of hierarchisation within both colonial and modern societies. As such, true decolonisation is only possible when both are addressed equally; failure to address the colonial root causes of gender-based inequalities will allow for the perpetuation of racialised notions of gender to persist across the global health ecosystem. However, the authors note with concern the relative sidelining of gender within the decolonising global health discourse, especially as it navigates the critical transition from rhetoric to action.

    METHODS: A scoping review was conducted to locate where gender does, or does not, appear within the decolonising global health literature. The authors reviewed the decolonising global health literature available on Scopus and PubMed online databases to identify peer-reviewed papers with the search terms "(decoloni* or de-coloni*) OR (neocolonial or neo-colonial) AND 'global health'" in their title, abstract or keywords published by December 2022.

    RESULTS: Out of 167 papers on decolonising global health, only 53 (32%) had any reference to gender and only 26 (16%) explicitly engaged with gender as it intersects with (de)coloniality. Four key themes emerged from these 26 papers: an examination of coloniality's racialised and gendered nature; how this shaped and continues to shape hierarchies of knowledge; how these intertwining forces drive gendered impacts on health programmes and policies; and how a decolonial gender analysis can inform action for change.

    CONCLUSION: Historical legacies of colonisation continue to shape contemporary global health practice. The authors call for the integration of a decolonial gender analysis in actions and initiatives that aim to decolonise global health, as well as within allied movements which seek to confront the root causes of power asymmetries and inequities.

    Matched MeSH terms: Global Health*
  15. Patwardhan B, Wieland LS, Aginam O, Chuthaputti A, Ghelman R, Ghods R, et al.
    Complement Ther Med, 2023 Oct;77:102970.
    PMID: 37591416 DOI: 10.1016/j.ctim.2023.102970
    Matched MeSH terms: Global Health*
  16. Patwardhan B, Wieland LS, Aginam O, Chuthaputti A, Ghelman R, Ghods R, et al.
    Natl Med J India, 2023;36(6):345-350.
    PMID: 38909307 DOI: 10.25259/NMJI_825_2023
    Matched MeSH terms: Global Health*
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links